Cargando…

A 15-Gene-Based Risk Signature for Predicting Overall Survival in SCLC Patients Who Have Undergone Surgical Resection

SIMPLE SUMMARY: Small cell lung cancer (SCLC) is a high-grade neuroendocrine carcinoma with a poor prognosis, accounting for approximately 15% of lung cancer cases. Acquired resistance to standard chemotherapy is quite common in SCLC patients, and the survival benefit of surgery and the selection of...

Descripción completa

Detalles Bibliográficos
Autor principal: Atay, Sevcan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649828/
https://www.ncbi.nlm.nih.gov/pubmed/37958393
http://dx.doi.org/10.3390/cancers15215219

Ejemplares similares